Remarkably, the pharmacological activation of α7nAChR in WT mice following a nutritional challenge partially reversed steatosis [28], an effect that involves the regulation of lipogenesis via the regulation of fatty acid synthase (Fasn) expression [29]. The gene discussed is FASN; the disease is steatosis.